Tananbaum James B. Insider Trades

Insider Trading History

Track insider trading activity for Tananbaum James B.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Alumis
Alumis ALMS
10% owner
Holding Value $0 0 shares
Last Trade
Apr 01, 2026 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$25.5M 1,123,337 shares
$22.73
$20.08
Alumis
Alumis ALMS
10% owner
Holding Value $22.6M 1,123,337 shares
Last Trade
Apr 01, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$41M 1,803,823 shares
$22.73
$20.08
Alumis
Alumis ALMS
10% owner
Holding Value $115M 5,702,536 shares
Last Trade
Jan 08, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7M 411,764 shares
$17.00
$20.08
Alumis
Alumis ALMS
10% owner
Holding Value $52.5M 2,614,215 shares
Last Trade
Nov 21, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$533k 72,212 shares
$7.38
$20.08
Alumis
Alumis ALMS
10% owner
Holding Value $51M 2,542,003 shares
Last Trade
Nov 19, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.25M 190,500 shares
$6.56
$20.08
Alumis
Alumis ALMS
10% owner
Holding Value $47.2M 2,351,503 shares
Last Trade
Nov 18, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$727k 117,374 shares
$6.19
$20.08
Alumis
Alumis ALMS
10% owner
Holding Value $44.9M 2,234,129 shares
Last Trade
Nov 17, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.12M 200,000 shares
$5.59
$20.08
Alumis
Alumis ALMS
10% owner
Holding Value $85.3M 4,247,670 shares
Last Trade
May 06, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$86.8k 20,000 shares
$4.34
$20.08
Alumis
Alumis ALMS
10% owner
Holding Value $84.9M 4,227,670 shares
Last Trade
May 02, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$116k 25,000 shares
$4.62
$20.08
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.54M 581,462 shares
$2.65
$2.65
Pardes Biosciences
Pardes Biosciences PRDS
10% owner, President And CEO
Holding Value $2.18k 1,000 shares
Last Trade
Aug 31, 2023 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.16k 1,000 shares
$2.16
$2.18
Pardes Biosciences
Pardes Biosciences PRDS
10% owner, President And CEO
Holding Value $0 0 shares
Last Trade
Aug 31, 2023 Purchase (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$81k 37,500 shares
$2.16
$2.18
Pardes Biosciences
Pardes Biosciences PRDS
10% owner
Holding Value $81.8k 37,500 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.1k 37,500 shares
$1.87
$2.18
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $9.34M 3,525,957 shares
Last Trade
May 08, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.98M 1,780,000 shares
$2.80
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $5.23M 1,975,001 shares
Last Trade
Feb 17, 2023 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$7.46M 1,100,000 shares
$6.78
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
Director
Holding Value $53.7k 20,250 shares
Last Trade
Jun 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$170k 20,250 shares
$8.38
$2.65
Pardes Biosciences
Pardes Biosciences PRDS
Director
Holding Value $81.8k 37,500 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195k 37,500 shares
$5.21
$2.18
FS Development II
FS Development II FSII
10% owner
Holding Value $47.8M 4,873,750 shares
Last Trade
Dec 23, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$47.8M 4,873,750 shares
$9.80
$9.80
FS Development II
FS Development II FSII
10% owner
Holding Value $76M 7,759,072 shares
Last Trade
Dec 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10M 1,000,000 shares
$10.00
$9.80
FS Development II
FS Development II FSII
10% owner
Holding Value $0 0 shares
Last Trade
Dec 23, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$47.8M 4,873,750 shares
$9.80
$9.80

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up